Study
Weight Loss and Omega-3 Supplementation Modulate the Microbiome in Women with Increased Breast Cancer Risk.
In a 34-person weight-loss pilot, 3.25 g/day omega-3 was associated with microbiome and breast-cancer-risk biomarker changes, not cancer outcomes.
Summary Can omega-3 supplements improve health changes during weight loss? Show / hide ↓
Researchers randomly assigned 34 peri- or postmenopausal women with a body mass index, a weight-to-height measure, of at least 28 to take 3.25 grams of omega-3 daily or a placebo, an inactive look-alike pill. Everyone also followed a behavioral weight-loss program and lost about 10% of their starting weight. The researchers examined the gut microbiome, the community of microbes living in the intestines, along with blood markers, measurable signs of health. Among women who lost at least 10% of their weight, omega-3 was linked with larger changes in the balance of two major types of gut bacteria and in inflammation and hormone-related markers. The study did not measure breast cancer cases, cancer recurrence, or lifespan, and it did not show whether omega-3 caused the changes.
What this means for you: This is too small and short to justify buying omega-3 for breast cancer prevention or longer life. It may be worth discussing for other established reasons, but this study alone provides little practical guidance.
weak evidenceThis pilot study randomised 34 peri- or postmenopausal women with body mass index at least 28 kg/m² to 3.25 g/day of omega-3 fatty acids or placebo during a behavioural weight-loss intervention. Median weight change was 10% below baseline. The study assessed body composition, faecal microbial populations, and blood markers rather than breast cancer incidence or recurrence. Among women who lost at least 10% of their weight, the omega-3 group had the largest fall in the Firmicutes:Bacteroidetes ratio and favourable changes in systemic biomarkers. The omega-3 group also showed increased proportional abundance of the short-chain-fatty-acid-producing microbes Phocaeicola vulgatus and Alistipes putredinis. Those changes correlated with bioavailable estradiol, adiponectin:leptin ratio, and C-reactive protein. Plasma propionate increased by percentage change, while butyrate decreased. Correlation does not establish that the microbial shifts caused the biomarker changes, and the abstract gives no arm-specific effect sizes or p-values. Omega-3 was added to weight loss, so the study cannot separate its contribution from weight reduction and related behavioural changes. It is a small, short-term biomarker study in a selected population, not evidence that omega-3 prevents breast cancer or extends life.
High-dose omega-3 added to behavioural weight loss promoted gut-microbiome shifts associated with improved breast-cancer-risk biomarkers.
This was a pilot study of 34 women and used microbiome and risk-factor biomarkers, not cancer outcomes. The reported findings were concentrated among those losing at least 10% of weight, and the abstract supplies no numerical between-group effects or p-values.
Cited by
1 encyclopedia entries reference this study.